# Novel Biomarkers in Inflammatory Bowel Disease

> **NCT03833310** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 70 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Osteoprotegerin, sRANKL, NfKB and TFF3 markers in serum in inflammatory bowel disease

## Key facts

- **NCT ID:** NCT03833310
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-04-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833310, "Novel Biomarkers in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03833310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*